AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
Váldodahkkit: | , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
Elsevier
2023-10-01
|
Ráidu: | IBRO Neuroscience Reports |
Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |